Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03450980 · ClinicalTrials.gov registry record
Mobile Medical Application for Cost-effective Strabismus Screening
A clinical trial of Strabismus, sponsored by Massachusetts Eye and Ear Infirmary.
- Completed
- Registry status
- 91
- Enrollment target
- 1
- Study location
NCT03450980: Completed study of Strabismus, sponsored by Massachusetts Eye and Ear Infirmary.
NCT03450980 is a study of Strabismus that has completed, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 91 participants, below the 721-participant average among 9 other Strabismus trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03450980, a study of Strabismus, has completed, sponsored by Massachusetts Eye and Ear Infirmary.
- COMPLETED
- Registry status
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
Develop and evaluate a new smartphone based app to screen for and measure eye misalignment (strabismus). The investigators will validate the app against simulated strabismus of known magnitude and common clinical tests. They will evaluate the app as a screening tool in high risk populations, to determine the sensitivity and specificity. They hypothesize that the app can measure to within 2 units (prism diopters) of the ground truth, and that it will be correlated with gold standard tests.
Primary Outcome
Linear regression analysis was used to compare the app measurements of strabismus angle to ground truth and gold standard measures. The outcome measure is the difference between the two methods, in terms of least square mean (LSM).
Conditions Studied
Study Locations (1)
Massachusetts
- Ophthalmology of Clinical Research Office, Mass Eye and Ear - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2025-01-30 |
What the finished NCT03450980 record still lists
NCT03450980 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 721-participant average among 9 other Strabismus trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Strabismus appearing as the primary indexed condition, and to 0 interventions.
NCT03450980 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03450980 about?
NCT03450980 is a clinical study titled "Mobile Medical Application for Cost-effective Strabismus Screening". Develop and evaluate a new smartphone based app to screen for and measure eye misalignment (strabismus). The investigators will validate the app against simulated strabismus of known magnitude and common clinical tests. They will evaluate the app as a screening tool in high risk populations, to dete...
What is the current status of trial NCT03450980?
This trial is currently completed. The enrollment target is 91 participants. The study started on 2018-02-01. Estimated completion is 2025-01-30.
What conditions does trial NCT03450980 study?
This clinical trial studies the following conditions: Strabismus.
Who is sponsoring clinical trial NCT03450980?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03450980 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Strabismus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03450980's enrollment target sits among peer trials
91 6th of 9 higher than 4 of 9 other Strabismus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Strabismus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetic Studies of Strabismus, Nystagmus, and Associated Disorders
RECRUITING
-
Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy
RECRUITING
-
The Alaska Oculocardiac Reflex Study
RECRUITING
-
Intraoperative OCT Guidance of Intraocular Surgery II
RECRUITING
-
Amblyopia (Lazy Eye) Treatment Study
COMPLETED · Phase 3
-
Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI